A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers
Clinical trial NCT06034015 · UNKNOWN
Trial details
- NCT number
- NCT06034015
- Sponsor
- Jiangsu Yahong Meditech Co., Ltd aka Asieris
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-09
- Primary completion
- 2024-01-19
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.